Simmons Hanly Conroy
Recent News About Simmons Hanly Conroy View More
-
Judge ends nearly all of class action vs Rush University Health over MyChart data
Plaintiffs alleged private data improperly ended up with Facebook, Google, Bidtellect -
Madigan continues to rake in donations from trial lawyers, despite federal corruption probe
State campaign finance disclosures reveal trial lawyers, their firms and political lobbying groups have donated more than $175,000 to Madigan's two campaign organizations since Sept. 30. -
Judge orders new trial, tosses $140M verdict vs AbbVie over Androgel testosterone drug
A federal judge has knocked down a $140 million verdict against pharmaceutical maker AbbVie, ordering a new trial over a man’s claims AbbVie’s Androgel testosterone replacement therapy drug caused him to suffer a heart attack. -
Verdict much lower, but AbbVie wants $3.2M award tossed in second testosterone class action test trial
North Chicago-based drugmaker AbbVie is resisting what it is calling a jury's “confused and inconsistent” $3.2 million verdict, after the company lost a second trial in Chicago federal court – one in which it was ordered to pay $147 million less than the first trial – over a man’s claims AbbVie allegedly failed to warn its product AndroGel could bring on a heart attack. -
Report: Asbestos litigation declines nationwide, slightly in Cook Co., still pervasive in three IL counties
As the number of new asbestos lawsuits declined nationally, activity in Illinois’ three hotbeds for asbestos litigation showed few signs of ebbing in 2017, even though the distribution of filing activity has shifted slightly. -
Plaintiff lawyers see nationwide settlement as only end for opioid lawsuits
SAN FRANCISCO (Legal Newsline) - Plaintiff lawyers meeting in San Francisco last week for a conference on opioid litigation acknowledged that the hundreds of lawsuits they have filed in state and federal court will be difficult to resolve without an unprecedented national settlement whose mechanics are still difficult to predict. -
IL appeals court upholds dismissal of class action challenging Chicago red light camera program law
Saying state law designates Chicago’s red light and speed camera enforcement programs as something different from ordinary traffic laws, a state appeals court has again handed a defeat to a class action attempting to overthrow the city’s automated traffic citation program, which annually adds millions of dollars in fines from ticketed motorists to the city’s coffers. -
Opioid judge doesn't want media to know details of settlement talks
CLEVELAND (Legal Newsline) - The judge overseeing multidistrict litigation against opioid manufacturers and distributors has named the teams of lawyers who will try to negotiate a settlement of hundreds of federal lawsuits - a complex task given parallel investigations and litigation by state attorneys general and potentially conflicting goals of private attorneys and their government counterparts. -
Jury declares Abbvie's Androgel didn't cause man's lung clots, Abbvie didn't falsely market medication
After split verdicts in two prior trials over alleged harmful side effects and alleged misleading marketing of its testosterone replacement drug led to questionable verdicts worth more than $140 million each, drugmaker Abbvie has scored a clean win in the latest jury review of a plaintiff’s claims over the promotion and health impacts of Androgel. -
Usual Suspects: Lawyers used to getting their way in MDL process to lead opioid litigation
CLEVELAND (Legal Newsline) - There will be a lot of familiar faces in U.S. District Judge Dan Polster’s courtroom in Cleveland on Jan. 31, when lawyers gather for a hearing on multidistrict litigation against the nation’s opioid manufacturers and distributors. -
Illinois Supreme Court mulling who gets consolidated opioid cases – Cook Co. or Springfield judge
SPRINGFIELD – Supreme Court Justices must decide whether suits that counties continue filing against opioid manufacturers belong with a judge from Cook County or a judge from Springfield. -
Contract: Simmons, Meyers firms to split 25 percent cut of Cook County's take from any opioid lawsuit payment
Lawyers hired by Cook County to help press the county’s case against drug companies over the proliferation of opioid painkillers stand to pocket at least a quarter of Cook County’s cut of any settlement or dollar amount awarded by a court. -
Attorney says 'no chance' that $140 million punitive damages judgment against AbbVie will stand
North Chicago-based drugmaker AbbVie has asked a federal judge to toss out a $140 million verdict against it for allegedly mismarketing its testosterone replacement therapy drug, Androgel. And in the view of a Chicago attorney whose practice focuses on Supreme Court and appellate cases, as well as class actions, there is "no chance" that judgment will be allowed to stand. -
Drug maker AbbVie wants to slip from $140M verdict, says jury ignored evidence
North Chicago-based drug company AbbVie is urging a federal judge to trash a verdict ordering it to cough up $140 million, because its testosterone therapy drug AndroGel contributed to a man's heart attack, contending it has no liability because AndroGel was approved by the FDA. -
Jury: Abbvie falsely marketed Androgel, owes man who suffered heart attack $140M
Drugmaker Abbvie has suffered another big loss in court, as a Chicago federal jury has ordered the North Chicago-based pharmaceutical company to pay out $140 million to another man who claimed he had suffered a heart attack as a result of taking Abbvie’s testosterone therapy drug, Androgel. -
Machinist's claims work fumes caused cancer vs Union Pacific, Safety Kleen headed back to Cook court
A machinist’s case against Union Pacific, claiming the railroad should be made to pay for allegedly exposing him to toxic fumes and products at work, allegedly causing his renal cancer, has been sent back to Cook County court, after a federal judge determined the Federal Employees Liability Act doesn't let it pull out of state court. -
Federal judge tosses some accusations vs testosterone drug makers on eve of Androgel bellwether trials
A Chicago federal judge has dismissed several. but not all of the claims against the maker of a testosterone boosting drug, advanced by several plaintiffs chosen as bellwethers in a class-action lawsuit brought by more than 2,000 plaintiffs from around the U.S. against multiple drug manufacturers, including Besins, AbbVie, Eli Lilly and GlaxoSmithKline. -
Big U.S. sales of Androgel sink Belgian drugmaker Besins' try to toss 'Low T' drug class action suit
A federal judge has denied a Belgian drug maker’s attempt to remove itself from a massive class-action lawsuit that claims testosterone replacement drugs caused harm to patients taking them for off-label conditions. -
Report: Political donations from trial lawyers topped $35 million in 15 years
A new study published by the Illinois Civil Justice League shows that campaign contributions from trial lawyers to Illinois politicians and judges topped $35.25 million during the past 15 years. The courts in Cook County, along with those in downstate Madison and St. Clair counties, near St. Louis, host the state’s highest concentrations of civil litigation, factor prominently in "Justice for Sale III," a report analyzing campaign contributions made by the plaintiffs' bar and the profound impact -
Questions raised over number of defendant companies named in asbestos suits; can number in hundreds
The average number of companies targeted by some of the biggest asbestos firms in their lawsuits is in the triple-figures, according to recent statistics, forcing some, especially those in claims management, to question the strategy of plaintiffs’ lawyers.